Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial.
Leukemia. 2023 Nov;37(11):2276-2281. doi: 10.1038/s41375-023-02034-4. Epub 2023 Sep 23.
Leukemia. 2023.
PMID: 37741948
No abstract available.
Genetic characteristics and treatment outcome in infants with KMT2A germline B-cell precursor acute lymphoblastic leukemia: Results of MLL-Baby protocol.
Popov A, Tsaur G, Permikin Z, Henze G, Verzhbitskaya T, Plekhanova O, Nokhrina E, Valochnik A, Sibiryakov P, Zerkalenkova E, Olshanskaya Y, Gindina T, Movchan L, Shorikov E, Streneva O, Khlebnikova O, Makarova O, Arakaev O, Boichenko E, Kondratchik K, Ponomareva N, Lapotentova E, Aleinikova O, Miakova N, Novichkova G, Karachunskiy A, Fechina L.
Popov A, et al. Among authors: lapotentova e.
Pediatr Blood Cancer. 2023 Apr;70(4):e30204. doi: 10.1002/pbc.30204. Epub 2023 Jan 30.
Pediatr Blood Cancer. 2023.
PMID: 36715125
Item in Clipboard
Incidence and prognostic value of central nervous system involvement in infants with B-cell precursor acute lymphoblastic leukemia treated according to the MLL-Baby protocol.
Popov A, Tsaur G, Permikin Z, Fominikh V, Verzhbitskaya T, Riger T, Demina A, Shorikov E, Kustanovich A, Movchan L, Streneva O, Khlebnikova O, Makarova O, Arakaev O, Solodovnikov A, Boichenko E, Kondratchik K, Ponomareva N, Lapotentova E, Aleinikova O, Miakova N, Novichkova G, Karachunskiy A, Fechina L.
Popov A, et al. Among authors: lapotentova e.
Pediatr Blood Cancer. 2022 Sep;69(9):e29860. doi: 10.1002/pbc.29860. Epub 2022 Jun 30.
Pediatr Blood Cancer. 2022.
PMID: 35713168
Item in Clipboard
Prognostic value of minimal residual disease measured by fusion-gene transcript in infants with KMT2A-rearranged acute lymphoblastic leukaemia treated according to the MLL-Baby protocol.
Tsaur G, Popov A, Riger T, Kustanovich A, Solodovnikov A, Shorikov E, Demina A, Verzhbitskaya T, Streneva O, Makarova O, Lapotentova E, Aleinikova O, Miakova N, Boichenko E, Kondratchik K, Ponomareva N, Karachunskiy A, Roumiantsev A, Fechina L.
Tsaur G, et al. Among authors: lapotentova e.
Br J Haematol. 2021 Jun;193(6):1151-1156. doi: 10.1111/bjh.17304. Epub 2021 Feb 14.
Br J Haematol. 2021.
PMID: 33583020
Clinical Trial.
Item in Clipboard
[Efficiency of the ALL-MB-2002 protocol in children with acute lymphoblastic leukemia].
Rumiantseva IuV, Karachunskiĭ AI, Aleĭnikova OV, Fechina LG, Shamardina AV, Litvinov DV, Ponomareva NI, Boĭchenko EG, Dudkin SA, Streneva OV, Kondratchik KL, Mansurova EG, Minkina LM, Lapotentova ES, Iniushkina EV, Iudina NB, Pavlova GP, Zhukovskaia EV, Khlebnikova OP, Lagoĭko SN, Basharova EV, Denisov RE, Zlobina VD, Banshchikova ES, Aslanian KS, Kondakova EV, Tselousova EV, Miakova NV, Turobova TV, Ryskal' OV, Chipsanova NF, Varfolomeeva SR, Rumiantsev AG.
Rumiantseva IuV, et al. Among authors: lapotentova es.
Ter Arkh. 2010;82(7):11-9.
Ter Arkh. 2010.
PMID: 20853603
Clinical Trial.
Russian.
Item in Clipboard
Cite
Cite